EURONEXT:SIGHT
GenSight Biologics S.A.
- Stock
Last Close
0.40
30/08 15:35
Market Cap
31.04M
Beta: 2.21
Volume Today
355.02K
Avg: 307.85K
PE Ratio
−0.65
PFCF: −0.75
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -4.15M - | -8.30M 100% | -10.16M 22.31% | -10.16M 0% | -5.36M 47.26% | -10.71M 100% | -8.46M 21.08% | -8.46M 0% | -5.98M 29.26% | -11.96M 100% | -7.13M 40.40% | -7.13M 0% | |
depreciation and amortization | 235.50K - | 432K 83.44% | 228.50K 47.11% | 228.50K 0% | 273K 19.47% | 484K 77.29% | 257.50K 46.80% | 257.50K 0% | 329K 27.77% | 495K 50.46% | 760.50K 53.64% | 760.50K 0% | |
deferred income tax | -6.05M - | 718K 111.87% | 718K 0% | -63K 108.77% | 1.40M 2,317.46% | ||||||||
stock based compensation | 757.50K - | 757.50K 0% | 1.66M 119.08% | 1.66M 0% | -809K 148.75% | -809K 0% | -873K 7.91% | -873K 0% | 83K 109.51% | 83K 0% | 211K 154.22% | 211K 0% | |
change in working capital | -1.67M - | -5.58M 233.87% | 2.89M 151.85% | 2.89M 0% | -712K 124.62% | -3.88M 444.66% | 155K 104.00% | 155K 0% | -20K 112.90% | 443K 2,315% | 3.18M 618.74% | 3.18M 0% | |
accounts receivables | -1.06M - | -3.90M 266.07% | 715K 118.36% | 715K 0% | 223K 68.81% | -3.44M 1,641.26% | 155K 104.51% | 155K 0% | -20K 112.90% | 347K 1,835.00% | 19.50K 94.38% | 19.50K 0% | |
inventory | |||||||||||||
accounts payables | -2.24M - | -2.45M - | 2.12M - | ||||||||||
other working capital | -607K - | 553K 191.10% | 2.18M 293.76% | 2.18M 0% | -935K 142.94% | 2.01M 315.29% | -2.03M - | 3.16M 256.12% | 3.16M 0% | ||||
other non cash items | -278.50K - | 9.92M 3,660.50% | 1.92M 80.69% | 1.92M 0% | -1.74M 190.78% | 3.92M 325.31% | -335K 108.55% | -335K 0% | -2.45M 631.94% | -6.93M 182.83% | -1.25M 81.92% | -1.25M 0% | |
net cash provided by operating activities | -5.11M - | -10.53M 106.15% | -3.46M 67.14% | -3.46M 0% | -8.34M 141.07% | -17.05M 104.35% | -8.53M 49.95% | -8.53M 0% | -8.10M 5.03% | -16.48M 103.34% | -4.23M 74.35% | -4.23M 0% | |
investments in property plant and equipment | -5K - | -10K 100% | -11K 10% | -11K 0% | -74.50K 577.27% | -149K 100% | -51.50K 65.44% | -51.50K 0% | -5K - | -5K 0% | |||
acquisitions net | |||||||||||||
purchases of investments | |||||||||||||
sales maturities of investments | 250K - | 242K - | 153K - | ||||||||||
other investing activites | 125K - | 125K 0% | -117K 193.60% | -117K 0% | 121K 203.42% | 91K - | 91K 0% | 76.50K 15.93% | 33K - | 33K 0% | |||
net cash used for investing activites | 120K - | 240K 100% | -128K 153.33% | -128K 0% | 46.50K 136.33% | 93K 100% | 39.50K 57.53% | 39.50K 0% | 76.50K 93.67% | 153K 100% | 28K 81.70% | 28K 0% | |
debt repayment | -1.04M - | -2.27M - | -7.08M - | ||||||||||
common stock issued | 28.10M - | 31K - | 53K - | ||||||||||
common stock repurchased | -125K - | -125K 0% | -27.50K 78% | -27.50K 0% | -121K 340% | -242K 100% | 49K - | -49.50K - | -49.50K 0% | ||||
dividends paid | |||||||||||||
other financing activites | 13.32M - | -74K 100.56% | -1.30M 1,655.41% | -1.30M 0% | -1.51M 16.24% | -1.63M 8.01% | 1.68M 202.91% | 1.63M 2.92% | 3.20M 96.62% | -453K 114.14% | 4.78M 1,154.08% | 4.78M 0% | |
net cash used provided by financing activities | 13.20M - | 26.71M 102.39% | -1.33M 104.97% | -1.33M 0% | -1.63M 22.96% | -2.90M 77.74% | 1.68M 157.90% | 1.68M 0% | 3.20M 90.88% | 6.68M 108.46% | 4.73M 29.25% | 4.73M 0% | |
effect of forex changes on cash | -48K - | -48K 0% | -71K 47.92% | -71K 0% | -143K 101.41% | -143K 0% | 46.50K 132.52% | 46.50K 0% | 28.50K 38.71% | 28.50K 0% | 31K 8.77% | 31K 0% | |
net change in cash | 8.16M - | 16.32M 100.01% | -4.99M 130.55% | -4.99M 0% | -10.07M 101.97% | -30.12M 199.05% | -6.77M 77.53% | -6.77M 0% | -4.79M 29.16% | -23.13M 382.27% | 557K 102.41% | 557K 0% | |
cash at beginning of period | 37.94M - | 54.26M 43.01% | 54.26M - | 24.15M 55.50% | 24.15M - | ||||||||
cash at end of period | 8.16M - | 54.26M 565.03% | 49.28M 9.19% | -4.99M 110.12% | -10.07M 101.97% | 24.15M 339.76% | 17.38M 28.03% | -6.77M 138.95% | -4.79M 29.16% | 1.02M 121.29% | 557K 45.45% | 557K 0% | |
operating cash flow | -5.11M - | -10.53M 106.15% | -3.46M 67.14% | -3.46M 0% | -8.34M 141.07% | -17.05M 104.35% | -8.53M 49.95% | -8.53M 0% | -8.10M 5.03% | -16.48M 103.34% | -4.23M 74.35% | -4.23M 0% | |
capital expenditure | -5K - | -10K 100% | -11K 10% | -11K 0% | -74.50K 577.27% | -149K 100% | -51.50K 65.44% | -51.50K 0% | -5K - | -5K 0% | |||
free cash flow | -5.11M - | -10.54M 106.14% | -3.47M 67.06% | -3.47M 0% | -8.42M 142.45% | -17.20M 104.31% | -8.58M 50.09% | -8.58M 0% | -8.10M 5.60% | -16.48M 103.34% | -4.23M 74.32% | -4.23M 0% |
All numbers in EUR (except ratios and percentages)